Trial Profile

Phase II Clinical Study on the Efficacy and Safety of BAT5906 Injection in Patients With Wet Age-Related Macular Degeneration

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 19 Apr 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BAT 5906 (Primary)
Indications Wet age-related macular degeneration
Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
Sponsors Bio-Thera Solutions

Most Recent Events

30 Nov 2021 Status changed from not yet recruiting to completed.
04 Aug 2020 Planned number of patients changed to 48.
04 Aug 2020 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com